Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism
Open Access
- 6 December 2006
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (49) , 12748-12757
- https://doi.org/10.1523/jneurosci.3873-06.2006
Abstract
Brain-derived neurotrophic factor (BDNF) polymorphism is associated with the pathophysiology of several neurodegenerative disorders, including Huntington9s disease. In view of these data and the involvement of huntingtin in intracellular trafficking, we examined the intracellular transport and release of Val66Val BDNF (Val-BDNF) and Val66Met BDNF (Met-BDNF) in transfected striatal knock-in cells expressing wild-type or mutant full-length huntingtin. Colocalization studies with specific markers for endoplasmic reticulum showed no differences between the Val-BDNF and Met-BDNF and were not modified by mutant huntingtin. However, post-Golgi trafficking was altered by mutant huntingtin dependent on the BDNF form. Thus, fluorescence recovery after photobleaching (FRAP) and inverse FRAP analysis showed retention of Met-BDNF in the Golgi apparatus with respect to Val-BDNF in wild-type cells. Strikingly, mutant huntingtin diminished post-Golgi trafficking of Val-BDNF, whereas Met-BDNF was not modified. Accordingly, a reduction in the number of transport vesicles was only observed in mutant huntingtin cells transfected with Val-BDNF but not Met-BDNF. Moreover, mutant huntingtin severely affected the KCl-evoked release of Val-BDNF, although it had little effect on Met-BDNF regulated release. The constitutive release of Val-BDNF or Met-BDNF in mutant cells was only slightly reduced. Interestingly, mutant huntingtin only perturbed post-Golgi trafficking of proteins that follow the regulated secretory pathway (epidermal growth factor receptor or atrial natriuretic factor), whereas it did not change those that follow the constitutive pathway (p75NTR). We conclude that mutant huntingtin differently affects intracellular transport and release of Val-BDNF and Met-BDNF. In addition, our findings reveal a new role for huntingtin in the regulation of the post-Golgi trafficking of the regulated secretory pathway.Keywords
This publication has 50 references indexed in Scilit:
- Genetic analysis of candidate genes modifying the age-at-onset in Huntington’s diseaseHuman Genetics, 2006
- Sortilin Controls Intracellular Sorting of Brain-Derived Neurotrophic Factor to the Regulated Secretory PathwayJournal of Neuroscience, 2005
- Brain-Derived Neurotrophic Factor Regulates the Onset and Severity of Motor Dysfunction Associated with Enkephalinergic Neuronal Degeneration in Huntington's DiseaseJournal of Neuroscience, 2004
- Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populationsHuman Molecular Genetics, 2004
- Association Analysis of Brain-Derived Neurotrophic Factor Val66Met Polymorphisms with Alzheimer’s Disease and Age of OnsetNeuropsychobiology, 2004
- Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genesNature Genetics, 2003
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionPublished by Elsevier ,2003
- Activity-Dependent Transfer of Brain-Derived Neurotrophic Factor to Postsynaptic NeuronsScience, 2001
- Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathwaysCell, 1986
- Transit of epidermal growth factor through coated pits of the Golgi system.The Journal of cell biology, 1982